ABSTRACT
Optimal CD8 T cell immunity is orchestrated by signaling events initiated by TCR recognition of peptide Ag in concert with signals from molecules such as CD28 and 4-1BB. The molecular mechanisms underlying the temporal and spatial signaling dynamics in CD8 T cells remain incompletely understood. In this study, we show that stimulation of naive CD8 T cells with agonistic CD3 and CD28 Abs, mimicking TCR and costimulatory signals, coordinately induces 4-1BB and cRel to enable elevated cytosolic cRel:IκBα complex formation and subsequent 4-1BB-induced IκBα degradation, sustained cRel activation, heightened IL-2 production and T cell expansion. NfkbiaNES/NES CD8 T cells harboring a mutated IκBα nuclear export sequence abnormally accumulate inactive cRel:IκBα complexes in the nucleus following stimulation with agonistic anti-CD3 and anti-CD28 Abs, rendering them resistant to 4-1BB induced signaling and a disrupted chain of events necessary for efficient T cell expansion. Consequently, CD8 T cells in NfkbiaNES/NES mice poorly expand during viral infection, and this can be overcome by exogenous IL-2 administration. Consistent with cell-based data, adoptive transfer experiments demonstrated that the antiviral CD8 T cell defect in NfkbiaNES/NES mice was cell intrinsic. Thus, these results reveal that IκBα, via its unique nuclear export function, enables, rather than inhibits 4-1BB-induced cRel activation and IL-2 production to facilitate optimal CD8 T cell immunity.
Subject(s)
CD8-Positive T-Lymphocytes/immunology , Interleukin-2/metabolism , Mutation/genetics , NF-KappaB Inhibitor alpha/genetics , Oncogene Proteins v-rel/metabolism , Active Transport, Cell Nucleus , Adoptive Transfer , Animals , Antibodies, Monoclonal/metabolism , CD28 Antigens/immunology , Cells, Cultured , Lymphocyte Activation , Mice , Mice, Inbred C57BL , Mice, Transgenic , NF-KappaB Inhibitor alpha/metabolism , Oncogene Proteins v-rel/genetics , Receptors, Antigen, T-Cell/metabolism , Signal Transduction , Tumor Necrosis Factor Receptor Superfamily, Member 9/metabolismABSTRACT
Rhipicephalus microplus is an important biological vector of Anaplasma marginale, the etiological agent of bovine anaplasmosis. The knowledge of tick immune responses to control bacterial infections remains limited. In this study, we demonstrate that transcription factor Relish from the IMD signaling pathway has an important role in the control of A. marginale infection in ticks. We found that RNA-mediated silencing of Relish caused a significant increase in the number of A. marginale in the midgut and salivary glands of R. microplus. In addition, the IMD pathway regulates the expression of the gene that encodes the antimicrobial peptide (AMP) microplusin. Moreover, microplusin expression was up-regulated in the midgut (2×) and salivary glands (8×) of A. marginale infected R. microplus. Therefore, it is plausible to hypothesize that microplusin may be involved in the A. marginale control. This study provides the first evidence of IMD signaling pathway participation on the A. marginale control in R. microplus.
Subject(s)
Anaplasma marginale/immunology , Anaplasmosis/immunology , Insect Proteins/metabolism , Oncogene Proteins v-rel/metabolism , Protein-Tyrosine Kinases/metabolism , Rhipicephalus sanguineus/immunology , Salivary Glands/physiology , Agammaglobulinaemia Tyrosine Kinase , Animals , Antimicrobial Cationic Peptides/genetics , Antimicrobial Cationic Peptides/metabolism , Cattle , Immunity, Innate , Insect Proteins/genetics , Male , Oncogene Proteins v-rel/genetics , RNA, Small Interfering/genetics , Receptor Cross-Talk , Rhipicephalus sanguineus/genetics , Salivary Glands/microbiology , Signal TransductionABSTRACT
The v-rel oncoprotein encoded by reticuloendotheliosis virus T strain (Rev-T) is a member of the rel/NF-κB family of transcription factors capable of transformation of primary chicken spleen and bone marrow cells. Rapid transformation of avian haematopoietic cells by v-rel occurs through a process of deregulation of multiple protein-encoding genes through its direct effect on their promoters. More recently, upregulation of oncogenic miR-155 and its precursor pre-miR-155 was demonstrated in both Rev-T-infected chicken embryo fibroblast cultures and Rev-T-induced B-cell lymphomas. Through electrophoresis mobility shift assay and reporter analysis on the gga-miR-155 promoter, we showed that the v-rel-induced miR-155 overexpression occurred by the direct binding to one of the putative NF-κB binding sites. Using the v-rel-induced transformation model on chicken embryonic splenocyte cultures, we could demonstrate a dynamic increase in miR-155 levels during the transformation. Transcriptome profiles of lymphoid cells transformed by v-rel showed upregulation of miR-155 accompanied by downregulation of a number of putative miR-155 targets such as Pu.1 and CEBPß. We also showed that v-rel could rescue the suppression of miR-155 expression observed in Marek's disease virus (MDV)-transformed cell lines, where its functional viral homologue MDV-miR-M4 is overexpressed. Demonstration of gene expression changes affecting major molecular pathways, including organismal injury and cancer in avian macrophages transfected with synthetic mature miR-155, underlines its potential direct role in transformation. Our study suggests that v-rel-induced transformation involves a complex set of events mediated by the direct activation of NF-κB targets, together with inhibitory effects on microRNA targets.
Subject(s)
Cell Transformation, Viral , Host-Pathogen Interactions , Oncogene Proteins v-rel/metabolism , RNA, Messenger/biosynthesis , Reticuloendotheliosis virus/pathogenicity , Animals , Cells, Cultured , Chickens , Gene Expression Profiling , Leukocytes, Mononuclear/virology , Promoter Regions, Genetic , Protein BindingABSTRACT
miR5745p has been reported involved in the pathogenesis of numerous human malignancies such as colorectal and lung cancer. In this study, we aimed to explore the roles of REL and miR574 in the recurrence of prostate cancer (PCa) and to identify the underlying molecular mechanisms. Our literature search found that miR574 is regulated in cancer stem cells (CSCs), and next we used the microRNA (miRNA) database (www.mirdb.org) to find REL as a target of miR574. Luciferase assay was performed to verify the miRNA/target relationship. Oligo-transfection, realtime PCR and western blot analysis were used to support the conclusions. We validated REL to be the direct gene via luciferase reporter assay system, and realtime PCR and western blot analysis were also conducted to study the mRNA and protein expression level of REL between different groups (recurrence and nonrecurrence) or cells treated with scramble control, miR574 mimics, REL siRNA and miR574 inhibitors, indicating the negative regulatory relationship between miR574 and REL. We also investigated the relative viability of prostate CSCs when transfected with scramble control, miR574 mimics, REL siRNA and miR574 inhibitors to validate miR574 to be positively interfering with the viability of prostate CSCs. We then investigated the relative apoptosis of prostate CSCs when transfected with scramble control, miR574 mimics, REL siRNA and miR574 inhibitors. The results showed miR574 inhibited apoptosis. In conclusion, miR574 might be a novel prognostic and therapeutic target in the management of PCa recurrence.
Subject(s)
MicroRNAs/physiology , Neoplasm Recurrence, Local/metabolism , Neoplastic Stem Cells/metabolism , Oncogene Proteins v-rel/genetics , Prostatic Neoplasms/metabolism , 3' Untranslated Regions , Base Sequence , Binding Sites , Cell Line, Tumor , Down-Regulation , Gene Expression , Gene Expression Regulation, Neoplastic , Humans , Male , Neoplasm Recurrence, Local/genetics , Oncogene Proteins v-rel/metabolism , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , RNA InterferenceABSTRACT
Psoriasis is a chronic skin disease that affects approximately 2% of the world's population. Conventional therapeutic approaches are not effective or necessarily safe for treating symptoms due to the serious side effects and resistance to currently prescribed drugs. Traditionally, in oriental medicine, apricot seed (Semen Armeniacae amarum) is used to treat skin diseases. However, the underlying mechanism of action has not been systematically elucidated. In the present study, the anti-proliferative effect of bitter apricot essential oil (BAEO) on cultured HaCaT cells was evaluated and the mechanism of action investigated. BAEO was isolated by hydrodistillation, and gas chromatography-mass spectrometry (GC-MS) analysis identified benzaldehyde (75.35%), benzoic acid (6.21%) and mandelonitrile (5.38%). HaCaT cell growth, measured by sulforhodamine B assay (SRB), was inhibited by BAEO with an IC50 value of 142.45 µg/ml. Apoptosis of HaCaT cells treated with BAEO was detected by cell cycle, flow cytometry, and western blot analyses. These measurements revealed G0/G1 cell cycle arrest, elevated numbers of early and late stage apoptotic cells, and caspases-3/8/9 and PARP activation. Z-VAD-FMK, a broad-spectrum caspase inhibitor, attenuated BAEO-induced apoptosis. Also, increased Bax and decreased Bcl-2 levels suggest that BAEO-induced apoptosis is mediated through both death receptor and mitochondrial pathways. Moreover, reduced Rel/NF-κB levels suggest that BAEO-mediated apoptosis is also associated with inhibition of the NF-κB pathway. These data suggest that BAEO is a naturally occurring material that functions as a potent pro-apoptotic factor for human keratinocytes. Thus, it is a promising candidate to treat psoriasis.
Subject(s)
Keratinocytes/drug effects , Mitochondria/drug effects , Oils, Volatile/pharmacology , Prunus armeniaca/immunology , Psoriasis/drug therapy , Amino Acid Chloromethyl Ketones/pharmacology , Apoptosis/drug effects , Caspases/metabolism , Cell Line , Humans , Keratinocytes/physiology , NF-kappa B/metabolism , Oncogene Proteins v-rel/metabolism , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Receptors, Death Domain/metabolism , Signal Transduction/drug effectsABSTRACT
The NF-κB/Rel signalling pathway plays a crucial role in numerous biological processes, including innate and adaptive immunity. NF-κB is a family of transcription factors, whose activity is regulated by the inhibitors of NF-κB (IκB). The IκB proteins comprise two distinct groups, the classical (cytoplasmic) and the atypical (nuclear) IκB proteins. Although the cytoplasmic regulation of NF-κB is well characterised, its nuclear regulation mechanisms remain marginally elucidated. However, work from recent years indicated that nuclear IκBs contribute significantly to the modulation of NF-κB-mediated transcription in the immune system. Here, we discuss the role of the atypical IκB proteins Bcl-3, IκBζ, IκBNS, IκBη and IκBL for the regulation of gene expression and effector functions in immune cells.
Subject(s)
I-kappa B Kinase/immunology , Macrophages/immunology , NF-kappa B/metabolism , Nuclear Proteins/immunology , T-Lymphocytes/immunology , Animals , Cell Differentiation , Humans , Immunity , Immunomodulation , NF-kappa B/immunology , Oncogene Proteins v-rel/metabolism , Signal TransductionABSTRACT
Biomphalaria glabrata acts as the intermediate host to the parasite, Schistosoma mansoni, and for this reason, the immune system of B. glabrata has been researched extensively. Several studies have demonstrated that the transcriptome profile of B. glabrata changes following exposure to a variety of pathogens, yet very little is known regarding the regulation of gene expression in this species. Nuclear factor kappaB (NF-κB) homologues have recently been identified in B. glabrata but few functional studies have been carried out on this family of transcription factors. The aims of this study therefore were to identify NF-κB binding sites (κB motifs) in B. glabrata and examine them via functional assays. Two different κB motifs were predicted. Furthermore, the Rel homology domain (RHD) of a B. glabrata NF-κB was able to bind these κB motifs in EMSAs, as well as a vertebrate κB motif.
Subject(s)
Biomphalaria/immunology , NF-kappa B/metabolism , Oncogene Proteins v-rel/metabolism , Schistosoma mansoni/physiology , Schistosomiasis mansoni/physiopathology , Amino Acid Motifs/genetics , Animals , Binding Sites/genetics , Electrophoretic Mobility Shift Assay , Host-Parasite Interactions , Humans , Immunity, Innate , Life Cycle Stages , NF-kappa B/genetics , Protein Binding , TranscriptomeABSTRACT
Vibrio harveyi is a marine bacterial pathogen responsible for episodic abalone mortalities in France, Japan and Australia. In the European abalone, V. harveyi invades the circulatory system in a few hours after exposure and is lethal after 2 days of infection. In this study, we investigated the responses of European abalone immune cells over the first 24 h of infection. Results revealed an initial induction of immune gene expression including Rel/NF-kB, Mpeg and Clathrin. It is rapidly followed by a significant immuno-suppression characterized by reduced cellular hemocyte parameters, immune response gene expressions and enzymatic activities. Interestingly, Ferritin was overexpressed after 24 h of infection suggesting that abalone attempt to counter V. harveyi infection using soluble effectors. Immune function alteration was positively correlated with V. harveyi concentration. This study provides the evidence that V. harveyi has a hemolytic activity and an immuno-suppressive effect in the European abalone.
Subject(s)
Ferritins/metabolism , Gastropoda/immunology , Hemocytes/immunology , Vibrio Infections/immunology , Vibrio/immunology , Animals , Clathrin/genetics , Clathrin/metabolism , Europe , Ferritins/genetics , Gene Expression Regulation , Hemocytes/microbiology , Hemolysis , Immunity , Immunomodulation , NF-kappa B/genetics , NF-kappa B/metabolism , Oncogene Proteins v-rel/genetics , Oncogene Proteins v-rel/metabolismABSTRACT
NF-κB, which comprises homo- and hetero-dimers of the five members of the Rel family, plays a crucial role in immunity to infection. The cRel and p50 subunits have been implicated in the development and function of the immune cells, but their in vivo importance remains poorly explored in sepsis. We aimed to study the impact of the combined loss of these two subunits on the innate response to infection in a cecal ligation and puncture model of sepsis. We have explored the possible defects in host defense, including pathogen clearance, bacterial phagocytosis and cytokine plasma release. We also performed gene profiling of cRel(-/-)p50(-/-) and wild-type LPS-stimulated peritoneal macrophages. Deficiency of cRel and p50 led to enhanced mortality to sepsis that was associated with defective macrophages phagocytosis, decreased bacterial clearance and moderate cytokine response. Transcription profile analysis revealed a common inflammatory response but a significant down-regulated transcription of genes encoding for pathogen recognition receptors and antimicrobial molecules, supporting the in vivo findings in mice. In conclusion, the cRel and p50 subunits of NF-κB play an important combined role in the innate response and are crucial for survival and pathogen clearance in polymicrobial sepsis.
Subject(s)
Macrophages/immunology , NF-kappa B p50 Subunit/metabolism , NF-kappa B/metabolism , Oncogene Proteins v-rel/metabolism , Sepsis/immunology , Animals , Cecum , Cells, Cultured , Female , Gene Expression Profiling , Humans , Immunity, Innate/genetics , Ligation , Lipopolysaccharides/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Models, Animal , Mutant Proteins/genetics , NF-kappa B/genetics , NF-kappa B p50 Subunit/genetics , Oncogene Proteins v-rel/genetics , Punctures , Sepsis/geneticsABSTRACT
The stringent response of Mycobacterium tuberculosis is coordinated by Rel and is required for full virulence in animal models. A serological-based approach identified Wag31(Mtb) as a protein that is upregulated in M. tuberculosis in a rel-dependent manner. This positive regulation was confirmed by analysis of M. tuberculosis mRNA expression. Mycobacterium smegmatis was used to confirm that the expression of wag31(Mtb) from its native promoter is positively regulated by the stringent response. Furthermore, elevated wag31(Mtb) expression in M. smegmatis drastically alters the cell-surface hydrophobic properties.
Subject(s)
Bacterial Proteins/genetics , Mycobacterium tuberculosis/genetics , Up-Regulation , Bacterial Proteins/metabolism , Gene Expression Regulation, Bacterial , Mycobacterium tuberculosis/metabolism , Oncogene Proteins v-rel/genetics , Oncogene Proteins v-rel/metabolismABSTRACT
v-rel, encoded by the avian reticuloendotheliosis virus, is an acutely transforming member of the Rel/NF-κB family of transcription factors. Transformation by v-Rel is mediated by the aberrant expression of genes that are normally regulated by Rel/NF-κB. Here, we demonstrate activation of the TGF-ß/Smad signaling pathway in Rel transformation. RNA and protein levels of key TGF-ß and Smad family members (TGF-ß2, -ß3, TGF-ß type II receptor, and Smad3) are upregulated in v-Rel transformed cells with little to no change in c-Rel-expressing cells. Treatment of v-Rel transformed lymphoid cells with kinase inhibitors of the TGF-ß receptor dramatically reduces soft agar colony formation whereas addition of TGF-ß2 further promotes transformation. Moreover, Smad3 but not Smad2, is selectively activated as the downstream mediator of TGF-ß signaling. Blocking Smad3 expression or activity inhibits the oncogenic potential of v-Rel. Overall, TGF-ß/Smad signaling is activated at multiple levels and is required for the transforming ability of v-Rel.
Subject(s)
Cell Transformation, Neoplastic/metabolism , Oncogene Proteins v-rel/metabolism , Signal Transduction , Smad Proteins/metabolism , Transforming Growth Factor beta/metabolism , Animals , Cell Line , Cell Transformation, Neoplastic/genetics , Chickens , Gene Expression Regulation , Oncogene Proteins v-rel/genetics , Receptors, Transforming Growth Factor beta/genetics , Receptors, Transforming Growth Factor beta/metabolism , Reticuloendotheliosis Viruses, Avian , Smad Proteins/genetics , Transforming Growth Factor beta/geneticsABSTRACT
Cell-surface protein CD10 is a prognostic marker for diffuse large B-cell lymphoma (DLBCL), where high expression of CD10 is found in the germinal center B-cell (GCB) subtype and CD10 expression is low or absent in the activated B-cell (ABC) subtype. As compared with the GCB subtype, patients with ABC DLBCL have a poorer prognosis after standard treatment, and ABC tumor cells have higher NF-κB activity. Herein, we show that increased expression of the NF-κB target micro-RNA miR-155 is correlated with reduced expression of transcription factor PU.1 and CD10 in several B-lymphoma cell lines. Moreover, electromobility shift assays and luciferase reporter assays indicate that PU.1 can directly activate expression from the CD10 promoter. Expression of a DLBCL-derived mutant of the adaptor CARD11 (a constitutive activator of NF-κB) in the GCB-like human BJAB cell line or v-Rel in the chicken DT40 B-lymphoma cell line causes reduced expression of PU.1. The CARD11 mutant also causes a decrease in CD10 levels in BJAB cells. Similarly, overexpression of miR-155, which is known to down-regulate PU.1, leads to reduced expression of CD10 in BJAB cells. Finally, we show that CD10 expression is reduced in BJAB cells after treatment with the NF-κB inducer lipopolysaccharide (LPS). Additionally, miR-155 is induced by LPS treatment or expression of the CARD11 mutant in BJAB cells. These results point to an NF-κB-dependent mechanism for down-regulation of CD10 in B-cell lymphoma: namely, that increased NF-κB activity leads to increased miR-155, which results in decreased PU.1, and consequently reduced CD10 mRNA and protein.
Subject(s)
Biomarkers, Tumor/biosynthesis , Gene Expression Regulation, Neoplastic , Lymphoma, Large B-Cell, Diffuse/metabolism , MicroRNAs/biosynthesis , NF-kappa B/metabolism , Neprilysin/biosynthesis , Proto-Oncogene Proteins/biosynthesis , Trans-Activators/biosynthesis , Animals , B-Lymphocytes/metabolism , Biomarkers, Tumor/genetics , CARD Signaling Adaptor Proteins , Cell Line, Transformed , Cell Line, Tumor , Chickens , Germinal Center/metabolism , Guanylate Cyclase , Humans , Lipopolysaccharides/pharmacology , Lymphocyte Activation/drug effects , Lymphocyte Activation/genetics , Lymphoma, Large B-Cell, Diffuse/diagnosis , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, Large B-Cell, Diffuse/therapy , MicroRNAs/genetics , Mutation , NF-kappa B/genetics , Neprilysin/genetics , Oncogene Proteins v-rel/genetics , Oncogene Proteins v-rel/metabolism , Prognosis , Promoter Regions, Genetic/genetics , Proto-Oncogene Proteins/genetics , Trans-Activators/geneticsABSTRACT
Cell transformation by the v-rel oncogene is mediated by the aberrant expression of genes that are normally tightly regulated by other Rel/NF-kappaB family members. Although a number of genes inappropriately activated or suppressed by v-Rel have been identified, their contributions to the v-Rel transformation process have been poorly characterized. Here, we examine the role of individual AP-1 proteins in v-Rel-mediated transformation. v-Rel-transformed cells exhibit elevated RNA and protein expression of c-Fos, c-Jun and ATF2 and sustained repression of Fra-2. c-Fos and c-Jun are essential in both the initiation and maintenance of v-Rel-mediated transformation, whereas Fra-2 is dispensable. By employing a c-Jun dimerization mutant, we further identified Fos/Jun heterodimers as major contributors to the v-Rel transformation process. The inability of c-Rel to induce the expression of c-Fos and c-Jun contributes to its weaker oncogenic potential relative to v-Rel. Our studies also demonstrate that v-Rel may induce AP-1 members by directly upregulating gene expression (c-fos and ATF2) and by activating pathways that stimulate AP-1 activity. Although elevated expression of ATF2 is also required for v-Rel-mediated transformation, its ectopic overexpression is inhibitory. Investigating the mode of ATF2 regulation revealed a positive feedback mechanism whereby ATF2 induces p38 MAPK phosphorylation to further induce its own activity. In addition, these studies identified Ha-Ras as an effector of v-Rel-mediated transformation and reveal a novel role for ATF2 in the inhibition of the Ras-Raf-MEK-ERK signaling pathway. Overall, these studies reveal distinct and complex roles of AP-1 proteins in Rel/NF-kappaB oncogenesis.
Subject(s)
Cell Transformation, Neoplastic , NF-kappa B/metabolism , Oncogene Proteins v-rel/metabolism , Transcription Factor AP-1/metabolism , Activating Transcription Factor 2/metabolism , Animals , Cell Line , Cells, Cultured , Chick Embryo , DNA/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Gene Expression Regulation , Humans , MAP Kinase Signaling System , Mitogen-Activated Protein Kinase Kinases/metabolism , Oncogene Proteins v-rel/genetics , Proto-Oncogene Proteins c-fos/metabolism , Proto-Oncogene Proteins c-jun/metabolism , Proto-Oncogene Proteins p21(ras)/metabolism , raf Kinases/metabolismABSTRACT
The peptidyl-prolyl isomerase Pin1 is frequently up-regulated in human cancers in which Rel/nuclear factor-kappaB (NF-kappaB) is constitutively activated, but its role in these cancers remains to be determined, and evidence is still lacking to show that Pin1 contributes to cell transformation by Rel/NF-kappaB. Rel/NF-kappaB transcriptional and oncogenic activities are modulated by several posttranslational modifications and coregulatory proteins, and previous studies showed that cytokine treatment induces binding of Pin1 to the RelA subunit of NF-kappaB, thereby enhancing RelA nuclear localization and stability. Here we show that Pin1 associates with the Rel subunits of NF-kappaB that are implicated in leukemia/lymphomagenesis and modulates their transcriptional and oncogenic activities. Pin1 markedly enhanced transformation of primary lymphocytes by the human c-Rel protein and also increased cell transformation by the potent viral Rel/NF-kappaB oncoprotein v-Rel, in contrast to a Pin1 mutant in the WW domain involved in interaction with NF-kappaB. Pin1 promoted nuclear accumulation of Rel proteins in the absence of activating stimuli. Importantly, inhibition of Pin1 function with the pharmacologic inhibitor juglone or with Pin1-specific shRNA led to cytoplasmic relocalization of endogenous c-Rel in human lymphoma-derived cell lines, markedly interfered with lymphoma cell proliferation, and suppressed endogenous Rel/NF-kappaB-dependent gene expression. Together, these results show that Pin1 is an important regulator of Rel/NF-kappaB transforming activity and suggest that Pin1 may be a potential therapeutic target in Rel/NF-kappaB-dependent leukemia/lymphomas.
Subject(s)
Cell Transformation, Neoplastic/genetics , Oncogene Proteins v-rel/physiology , Peptidylprolyl Isomerase/physiology , Amino Acid Sequence , Animals , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cell Proliferation/drug effects , Cells, Cultured , Chickens , Humans , Lymphoma/pathology , Molecular Sequence Data , Multigene Family/physiology , NF-kappa B/genetics , NF-kappa B/physiology , NIMA-Interacting Peptidylprolyl Isomerase , Naphthoquinones/pharmacology , Oncogene Proteins v-rel/genetics , Oncogene Proteins v-rel/metabolism , Peptidylprolyl Isomerase/antagonists & inhibitors , Peptidylprolyl Isomerase/genetics , Peptidylprolyl Isomerase/metabolism , Protein Binding , Protein Transport/drug effects , Protein Transport/genetics , Sequence Homology, Amino Acid , Up-Regulation/geneticsABSTRACT
Tyrosine kinase receptors such as members of the epidermal growth factor receptor family and their respective ligands are frequently overexpressed in pancreatic cancer as well as in chronic pancreatitis. In this study, the role of ErbB2 in the exocrine pancreas was examined by ectopic overexpression under the control of the proximal rat elastase promoter. Three independent transgenic mouse lines overexpressing ErbB2 were established by pronuclear injection. Pancreatic mRNA and protein levels were analyzed by real time PCR, immunohistochemistry and immunoblot analysis, RAS activity by using a specific immunoprecipitation assay and various kinase activities by phosphospecific antibodies. Overexpression of ErbB2 in the exocrine pancreas resulted in increased RAS activity and downstream activation of ERK1/2, but not in transgenic increased proliferation of acinar and ductal cells. At later timepoints, some mice showed focal areas of acinar cell damage with upregulated mRNA levels for Cyclin D1 and p16(INK4a). Despite the increased mRNA level, cyclin D1 protein levels were downregulated. We observed areas of focal infiltrations with inflammatory cells interspersed in the exocrine pancreas. NF-kappaB activity was induced in transgenic acinar cells compared with controls contributing to high levels of chemokine and cytokine gene expression such as CCR-1 and CCL3. These data suggest that overexpression of ErbB2 in acinar cells leads to increased RAS activity without cell cycle progression and mediates inflammation via NF-kappaB. We conclude that the biological response of ErbB2/RAS signaling depends highly on cellular context.
Subject(s)
Gene Expression Regulation , NF-kappa B/metabolism , Oncogene Proteins v-rel/metabolism , Pancreas, Exocrine/metabolism , Receptor, ErbB-2/genetics , Animals , Blotting, Western , Cell Proliferation , Cyclin D1/genetics , Cyclin D1/metabolism , Cyclin-Dependent Kinase Inhibitor p16/genetics , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Gene Expression Profiling , Humans , Immunohistochemistry , Inflammation/metabolism , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Transgenic , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Pancreas, Exocrine/cytology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Receptor, ErbB-2/metabolism , Reverse Transcriptase Polymerase Chain Reaction , ras Proteins/metabolismABSTRACT
v-Rel is the oncogenic member of the Rel/NF-kappaB family of transcription factors and transforms hematopoietic cells and fibroblasts. Differential display was employed to identify target genes that exhibit altered expression in v-Rel transformed cells. One of the cDNAs identified encodes the chicken ortholog of TC10, a member of the Rho small GTPase family. The expression of TC10 was increased in v-Rel-transformed chicken embryonic fibroblasts (CEFs) 3 to 6-fold relative to control cells at both the RNA and protein levels. An elevated level of active, GTP-bound TC10 was also detected in v-Rel-transformed cells relative to control cells. Expression of a dominant-negative TC10 mutant (TC10T32N) decreased the colony formation potential of v-Rel-transformed cells. Furthermore, overexpression of wild-type TC10 or a gain-of-function mutant (TC10Q76L) greatly enhanced the ability of v-Rel transformed CEFs to form colonies in soft agar. In addition to enhance the transformation potential of v-Rel, the overexpression of wild-type TC10 or the gain-of-function mutant alone enhanced the saturation density of CEFs and was sufficient for their anchorage-independent growth in vitro. These results indicate that elevated TC10 activity contributes to v-Rel-mediated transformation of CEFs and demonstrate for the first time that a Rho factor alone is capable of inducing the in vitro transformation of primary cells.
Subject(s)
Genes, rel , rho GTP-Binding Proteins/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Chick Embryo , Cloning, Molecular , Gene Expression Regulation, Neoplastic , Humans , Molecular Sequence Data , Oncogene Proteins v-rel/metabolism , Protein Biosynthesis , rho GTP-Binding Proteins/chemistry , rho GTP-Binding Proteins/geneticsABSTRACT
c-Rel is overexpressed in several B-cell lymphomas and c-rel gene overexpression can transform primary chicken lymphoid cells and induce tumors in animals. Although c-Rel is generally a stronger transcriptional activator than its viral derivative v-Rel, its oncogenic activity is significantly weaker. Among the mutations acquired during c-Rel's evolution into v-Rel are deletion of c-Rel's transactivation domain 2 (cTAD2) and mutations in cTAD1. Given the critical role of the Rel TADs in cell transformation, we investigated how mutations in c-Rel's cTAD1 and cTAD2 contribute to its oncogenicity and that of v-Rel. Mutations in cTAD2 noticeably increased c-Rel's transforming activity by promoting its nuclear localization and gene-specific transactivation, despite an overall decrease in kappaB site-dependent transactivation potency. Conversely, substitution of vTAD by cTAD1 increased v-Rel's transactivation and transforming efficiencies, whereas its substitution by the stronger cTAD2 compromised activation of mip-1beta but not irf-4 and was detrimental to cell transformation. These results suggest that the Rel TADs differentially contribute to gene-specific activation and that an optimal range of transcription potency is necessary for efficient transformation. These findings may have important implications for understanding how Rel TAD mutations can lead to a more oncogenic phenotype.
Subject(s)
Cell Nucleus/metabolism , Cell Transformation, Neoplastic/genetics , Proto-Oncogene Proteins c-rel/genetics , Transcriptional Activation , Amino Acid Sequence , Animals , Binding Sites , Cells, Cultured , Chickens , Electrophoretic Mobility Shift Assay , Humans , Immunoprecipitation , Lymphocytes/cytology , Lymphocytes/metabolism , Molecular Sequence Data , Mutation , Oncogene Proteins v-rel/genetics , Oncogene Proteins v-rel/metabolism , Protein Binding , Proto-Oncogene Proteins c-rel/metabolism , Transcription, GeneticABSTRACT
Genes that cause cancer have been divided into two general classes--oncogenes that act in a dominant fashion to transform normal cells into a malignant state, and tumor suppressor genes that act in a dominant fashion to prevent such transformation. In this report, we demonstrate that both the v-myb retroviral oncogene, which causes leukemic transformation of hematopoietic cells, and the c-myb proto-oncogene can also function as inhibitors of fibroblast transformation by the v-rel oncogene. These results imply that the myb genes can function either as oncogenes or as tumor suppressors in different cellular contexts.
Subject(s)
Cell Transformation, Neoplastic , Fibroblasts/pathology , Oncogene Proteins v-myb/metabolism , Oncogene Proteins v-rel/metabolism , Proto-Oncogene Proteins c-myb/metabolism , Actins/metabolism , Animals , Cell Extracts , Cell Nucleus/metabolism , Chickens , Fibroblasts/cytology , Mice , Oncogene Proteins v-myb/genetics , Proto-Oncogene Proteins c-myb/genetics , Proviruses/genetics , Quail , Receptors, Estrogen/metabolismABSTRACT
Studies on Drosophila immunity have focused on the humoral response, whereas less is known about the Drosophila cellular immunity. Here we show that mutants that lack the Drosophila Rel/NF-kappaB proteins Dorsal and Dif have very few blood cells, are constitutively infected by opportunistic microbes, and die from infection as larvae. When the double mutants are grown in microbe-free conditions, the animals are rescued from chronic infection and many survive to adult stages. Thus, Dif and Dorsal are required for survival because they protect the animal from infection by microbes from the environment. Specific expression of Dif or dorsal in the blood cell lineage is sufficient to restore blood cell number, clear microbes, and allow survival to the adult stage. These findings demonstrate that the cellular immune response is essential for the ability of Drosophila to survive in their standard laboratory environment, and that Dif and Dorsal control crucial aspects of the cellular immune response, including blood cell survival and the ability to fight off microbial infection.
Subject(s)
DNA-Binding Proteins/metabolism , Drosophila Proteins/metabolism , Drosophila melanogaster/immunology , Drosophila melanogaster/metabolism , NF-kappa B/metabolism , Nuclear Proteins/metabolism , Oncogene Proteins v-rel/metabolism , Phosphoproteins/metabolism , Transcription Factors/metabolism , Animals , Cell Proliferation , DNA-Binding Proteins/genetics , Drosophila Proteins/genetics , Drosophila melanogaster/genetics , Drosophila melanogaster/microbiology , Escherichia coli/immunology , Escherichia coli Infections/genetics , Escherichia coli Infections/immunology , Escherichia coli Infections/metabolism , Escherichia coli Infections/microbiology , Hemocytes/cytology , Hemocytes/metabolism , Immunity, Cellular , Larva/genetics , Larva/immunology , Larva/metabolism , Mutation/genetics , NF-kappa B/genetics , Nuclear Proteins/genetics , Oncogene Proteins v-rel/genetics , Opportunistic Infections/immunology , Opportunistic Infections/prevention & control , Phagocytes , Phosphoproteins/genetics , Survival Rate , Transcription Factors/geneticsABSTRACT
IkappaB kinase (IKK) alpha exhibits diverse biological activities through protein kinase-dependent and -independent functions, the former mediated predominantly through a noncanonical NF-kappaB activation pathway. The in vivo function of IKKalpha, however, still remains elusive. Because a natural strain of mice with mutant NF-kappaB-inducing kinase (NIK) manifests autoimmunity as a result of disorganized thymic structure with abnormal expression of Rel proteins in the thymic stroma, we speculated that the NIK-IKKalpha axis might constitute an essential step in the thymic organogenesis that is required for the establishment of self-tolerance. An autoimmune disease phenotype was induced in athymic nude mice by grafting embryonic thymus from IKKalpha-deficient mice. The thymic microenvironment that caused autoimmunity in an IKKalpha-dependent manner was associated with defective processing of NF-kappaB2, resulting in the impaired development of thymic epithelial cells. Thus, our results demonstrate a novel function for IKKalpha in thymic organogenesis for the establishment of central tolerance that depends on its protein kinase activity in cooperation with NIK.